Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Microfluidics-Based System Can Speed DNA Analysis

By LabMedica International staff writers
Posted on 10 Nov 2010
The multistep process needed for conventional DNA analysis requiring 8-10 hours can be completed in less than 60 minutes using a microfluidics-based system.

Data supported the capability of an integrated miniaturized system to produce rapid, automated, "sample in-answer out” analyses for accurate human identification, using standard buccal swab samples.

ZyGEM Corp. More...
Ltd., (Charlottesville, VA, USA) announced several developments supporting the advancement of its integrated microfluidics platform designed to dramatically decrease the time, complexity, and cost of conducting DNA testing.

The data were presented at the 21st International Symposium on Human Identification (ISHI), which was held October 11-14, 2010, in San Antonio (TX, USA). Scientists from ZyGEM's MicroLab unit together with the company's collaborators presented three sets of studies illustrating how the component elements of the prototype RapI.D. system act to speed the DNA analysis process.

RapI.D., which ZyGEM is developing in collaboration with Lockheed Martin), leverages MicroLab's advanced microfluidic research to accelerate the DNA identification process—essentially building a laboratory on a microfluidic chip that dramatically reduces the processing steps, time, and effort needed for analysis.

Three studies were presented at ISHI: the first study showed how the ZyGEM system conducts polymerase chain reaction (PCR) amplification up to 10 times more rapidly than conventional approaches, primarily by using infrared-mediated microchip PCR to reduce the time required for thermal cycling and holding. Infrared-mediated microchip PCR used far less reagent, required less sample, and was compatible with commercially available short tandem repeat (STR) amplification kits.

A second study presented at ISHI demonstrated that rapid microfluidic separations using the ZyGEM approach could be performed on two different detection systems using a plastic microchip, rather than the conventional glass microchip. The much cheaper plastic microchips worked as well as their glass counterparts, and could substantially decrease the overall cost of the analysis.

A third ISHI study assessed the overall performance of the prototype integrated microfluidics-based RapI.D. DNA analysis system ZyGEM is developing with Lockheed Martin. It showed that the multistep process for conventional forensic STR analysis requiring 8-10 hours was completed by the RapI.D. system in less than 60 minutes, extracting DNA from crude samples in as little as four minutes and completing the PCR amplification process in less than 40 minutes, using commercially available reagents.

Related Links:
ZyGEM Corp. Ltd.
Lockheed Martin


Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.